Cargando…

Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory

BACKGROUND: Implementation is proposed to be a multiphase, multilevel process. After a period of exploration, an adoption decision is made, typically at the upper management or policy level. Nevertheless, movement through each of the subsequent phases of the implementation process involves clinician...

Descripción completa

Detalles Bibliográficos
Autores principales: Moullin, Joanna C., Ehrhart, Mark G., Aarons, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027766/
https://www.ncbi.nlm.nih.gov/pubmed/29954409
http://dx.doi.org/10.1186/s13012-018-0782-1
_version_ 1783336665892257792
author Moullin, Joanna C.
Ehrhart, Mark G.
Aarons, Gregory A.
author_facet Moullin, Joanna C.
Ehrhart, Mark G.
Aarons, Gregory A.
author_sort Moullin, Joanna C.
collection PubMed
description BACKGROUND: Implementation is proposed to be a multiphase, multilevel process. After a period of exploration, an adoption decision is made, typically at the upper management or policy level. Nevertheless, movement through each of the subsequent phases of the implementation process involves clinicians or providers at the individual level to adopt the innovation and then change their behavior to use/deliver the innovation. Multiple behavioral change theories propose that intentions are a critical determinant of implementation behavior. However, there is a need for the development and testing of pragmatic measures of providers’ intentions to use a specific innovation or evidence-based practice (EBP). METHODS: Nine items were developed to assess providers’ intentions to use a specific innovation or EBP. Motivational interviewing was the EBP in the study. Items were administered, as part of larger survey, to 179 providers across 38 substance use disorder treatment (SUDT) programs within five agencies in California, USA. Rasch analysis was conducted using RUMM2030 software to assess the items, their overall fit to the Rasch model, the response scale used, individual item fit, differential item functioning (DIF), and person separation. RESULTS: Following a stepwise process, the scale was reduced from nine items to three items to increase the feasibility and acceptability of the scale while maintaining suitable psychometric properties. The three-item unidimensional scale showed good person separation (PSI = .872), no disordering of thresholds, and no evidence of uniform or non-uniform DIF. Rasch analysis supported the viability of the scale as a measure of implementation intentions. CONCLUSIONS: The Measure of Innovation-Specific Implementation Intentions (MISII) is a sound measure of providers’ intentions to use a specific innovation or EBP. Future evaluation of convergent, divergent, and predictive validity are needed. The study also demonstrates the value of Rasch analysis for testing the psychometric properties of pragmatic implementation measures.
format Online
Article
Text
id pubmed-6027766
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60277662018-07-09 Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory Moullin, Joanna C. Ehrhart, Mark G. Aarons, Gregory A. Implement Sci Research BACKGROUND: Implementation is proposed to be a multiphase, multilevel process. After a period of exploration, an adoption decision is made, typically at the upper management or policy level. Nevertheless, movement through each of the subsequent phases of the implementation process involves clinicians or providers at the individual level to adopt the innovation and then change their behavior to use/deliver the innovation. Multiple behavioral change theories propose that intentions are a critical determinant of implementation behavior. However, there is a need for the development and testing of pragmatic measures of providers’ intentions to use a specific innovation or evidence-based practice (EBP). METHODS: Nine items were developed to assess providers’ intentions to use a specific innovation or EBP. Motivational interviewing was the EBP in the study. Items were administered, as part of larger survey, to 179 providers across 38 substance use disorder treatment (SUDT) programs within five agencies in California, USA. Rasch analysis was conducted using RUMM2030 software to assess the items, their overall fit to the Rasch model, the response scale used, individual item fit, differential item functioning (DIF), and person separation. RESULTS: Following a stepwise process, the scale was reduced from nine items to three items to increase the feasibility and acceptability of the scale while maintaining suitable psychometric properties. The three-item unidimensional scale showed good person separation (PSI = .872), no disordering of thresholds, and no evidence of uniform or non-uniform DIF. Rasch analysis supported the viability of the scale as a measure of implementation intentions. CONCLUSIONS: The Measure of Innovation-Specific Implementation Intentions (MISII) is a sound measure of providers’ intentions to use a specific innovation or EBP. Future evaluation of convergent, divergent, and predictive validity are needed. The study also demonstrates the value of Rasch analysis for testing the psychometric properties of pragmatic implementation measures. BioMed Central 2018-06-28 /pmc/articles/PMC6027766/ /pubmed/29954409 http://dx.doi.org/10.1186/s13012-018-0782-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Moullin, Joanna C.
Ehrhart, Mark G.
Aarons, Gregory A.
Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory
title Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory
title_full Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory
title_fullStr Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory
title_full_unstemmed Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory
title_short Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory
title_sort development and testing of the measure of innovation-specific implementation intentions (misii) using rasch measurement theory
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027766/
https://www.ncbi.nlm.nih.gov/pubmed/29954409
http://dx.doi.org/10.1186/s13012-018-0782-1
work_keys_str_mv AT moullinjoannac developmentandtestingofthemeasureofinnovationspecificimplementationintentionsmisiiusingraschmeasurementtheory
AT ehrhartmarkg developmentandtestingofthemeasureofinnovationspecificimplementationintentionsmisiiusingraschmeasurementtheory
AT aaronsgregorya developmentandtestingofthemeasureofinnovationspecificimplementationintentionsmisiiusingraschmeasurementtheory